{"nct_id":"NCT02159053","title":"16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2015-05-18","start_date_type":"ACTUAL","primary_completion_date":"2016-02-23","primary_completion_date_type":"ACTUAL","completion_date":"2018-01-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}